SEC Charges Cardiologist in Biotech Drug Trial With Insider Trading
Dr. Edward Kosinski, the lead investigator in a heart drug trial, shorted the biotech firm's stock before bad news became public, the SEC said.
With Shares Up, AIG Executives Remain Optimistic
AIG shares increase on higher-than-expected second-quarter earnings as the company reshapes itself under intense pressure from institutional investors.
New Scottrade Tool Will Comb Social Media for Market Movers
Scottrade has partnered with social media analytics company Contix to track social media posts as a way for traders to identify financial events early.
Bill Gross Talks Birds, Bees and the Zero Bound
According to Janus manager Bill Gross, the toughest portfolio questions from investors pale in comparison to sex questions from your kids.
Best Finance Tweets: Party Conventions, July 2016
Fear and balloons take the national stage. Meanwhile, Motley Fool columnist Morgan Housel puts it all in perspective.
Answering the Hardest Question in Economics
Do low interest rates cause inflation, deflation or neither?
Are ‘Safe Haven’ Assets Safe Anymore?
"There is no safety in safety," says Tiger 21 founder Michael Sonnenfeldt.
Wealthy Investors to Reduce UK Exposure Following Brexit Vote
According to a deVere Group poll of clients, 69% intend to decrease their investment exposure to the U.K. for the remainder of 2016.
Clinton vs. Trump: 2 Wildly Different Tax, Economic Plans
Moody’s economist Mark Zandi analyzes how the candidates’ plans on taxes, trade and immigration would affect the economy.
College Endowments Seen Posting Worst Returns Since 2009
Funds with more than $500 million lost 0.73%, Wilshire says; universities set to report fiscal 2016 returns in the fall.